dc.contributor.author | Deighan, C | |
dc.contributor.author | Methven, L | |
dc.contributor.author | Naghadeh, MM | |
dc.contributor.author | Wokoma, A | |
dc.contributor.author | Macmillan, J | |
dc.contributor.author | Daly, CJ | |
dc.contributor.author | Tanoue, A | |
dc.contributor.author | Tsujimoto, G | |
dc.contributor.author | McGrath, JC | |
dc.date.accessioned | 2018-08-26T08:58:40Z | |
dc.date.available | 2018-08-26T08:58:40Z | |
dc.date.issued | 2005 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54722 | |
dc.description.abstract | ? 1-Adrenoceptor (AR) subtypes in mouse carotid arteries were characterised using a combination of agonist/antagonist pharmacology and knockout (KO) mice. Phenylephrine (PE) was most potent in the ? 1B-KO (pEC 50 = 6.9 آ± 0.2) followed by control (pEC 50 = 6.3 آ± 0.06) and ? 1D-KO (pEC 50 = 5.5 آ± 0.07). Both N-[5-(4,5-dihydro-1H-imidazol-2yl)- 2-hydroxy-5,6.7.8-tetrahydronaphthalen-1-yl] methanesulphonamide hydrobromide (A-61603) and 5-hydroxytryptamine (5-HT) were more potent in the ? 1D-KO (pEC 50 = 7.4 آ± 0.27 and 7.4 آ± 0.05, respectively) than the control (pEC 50 = 6.9 آ± 0.09 and 6.9 آ± 0.08, respectively) and equipotent with the control in the ? 1B-KO (pEC 50 = 6.7 آ± 0.07 and 6.8 آ± 0.04). Maximum responses to PE and A-61603 were reduced in the ? 1D-KO compared to control; there was no difference in maximum responses to 5-HT. In control arteries, prazosin and 5-methylurapidil acted competitively with pA 2 of 9.6 and 7.5, respectively. BMY7378 produced antagonism only at the highest concentration used (100 nMl; pK B 8.3). Prazosin, 5-methylurapidil and BMY7378 acted competitively in ? 1B-KO carotid arteries with pA 2 of 10.3, 7.6 and 9.6, respectively. In the ? 1D-KO, against PE, 5-methylurapidil produced a pA 2 of 8.1. pK B values were calculated for prazosin (10.6) and BMY7378 (7.0). Against A-61603, 5-methylurapidil had a pA 2 of 8.5, prazosin 8.6, while BMY7378 had no effect. In conclusion, the ? 1B-KO mediates contraction solely through ? 1D-ARs and the ? 1D-KO through ? 1A-ARs. Extrapolating back to the control from the knockout data suggests that all three subtypes could be involved in the responses, but we propose that the ? 1D-AR causes the contractile response and that the role of the ? 1B-AR is mainly regulatory. آ© 2005 Nature Publishing Group All rights reserved. | |
dc.language.iso | English | |
dc.relation.ispartof | British Journal of Pharmacology | |
dc.subject | 5 methylurapidil | |
dc.subject | 8 [2 [4 (2 methoxyphenyl) 1 piperazinyl]ethyl] 8 azaspiro[4.5]decane 7,9 dione | |
dc.subject | alpha 1 adrenergic receptor | |
dc.subject | alpha 1B adrenergic receptor | |
dc.subject | alpha 1D adrenergic receptor | |
dc.subject | n [5 (4,5 dihydro 1h imidazol 2 yl) 5,6,7,8 tetrahydro 2 hydroxy 1 naphthyl]methanesulfonamide | |
dc.subject | phenylephrine | |
dc.subject | prazosin | |
dc.subject | receptor subtype | |
dc.subject | serotonin | |
dc.subject | animal tissue | |
dc.subject | artery muscle | |
dc.subject | article | |
dc.subject | carotid artery | |
dc.subject | concentration response | |
dc.subject | controlled study | |
dc.subject | drug antagonism | |
dc.subject | drug competition | |
dc.subject | drug potency | |
dc.subject | knockout mouse | |
dc.subject | mouse | |
dc.subject | myography | |
dc.subject | nonhuman | |
dc.subject | priority journal | |
dc.subject | smooth muscle contractility | |
dc.subject | vascular smooth muscle | |
dc.subject | Adrenergic alpha-Agonists | |
dc.subject | Adrenergic alpha-Antagonists | |
dc.subject | Animals | |
dc.subject | Carotid Artery, Common | |
dc.subject | Dose-Response Relationship, Drug | |
dc.subject | Male | |
dc.subject | Mice | |
dc.subject | Mice, Knockout | |
dc.subject | Muscle Contraction | |
dc.subject | Muscle, Smooth, Vascular | |
dc.subject | Rats | |
dc.subject | Rats, Wistar | |
dc.subject | Receptors, Adrenergic, alpha-1 | |
dc.title | Insights into the functional roles of alpha; 1-adrenoceptor subtypes in mouse carotid arteries using knockout mice | |
dc.type | Article | |
dc.citation.volume | 144 | |
dc.citation.issue | 4 | |
dc.citation.spage | 558 | |
dc.citation.epage | 565 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.1038/sj.bjp.0706089 | |